David W. Ollila

12.7k total citations · 2 hit papers
173 papers, 8.1k citations indexed

About

David W. Ollila is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, David W. Ollila has authored 173 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Oncology, 83 papers in Cancer Research and 52 papers in Pathology and Forensic Medicine. Recurrent topics in David W. Ollila's work include Breast Cancer Treatment Studies (72 papers), Cutaneous Melanoma Detection and Management (52 papers) and Breast Lesions and Carcinomas (45 papers). David W. Ollila is often cited by papers focused on Breast Cancer Treatment Studies (72 papers), Cutaneous Melanoma Detection and Management (52 papers) and Breast Lesions and Carcinomas (45 papers). David W. Ollila collaborates with scholars based in United States, Australia and Germany. David W. Ollila's co-authors include Lisa A. Carey, Armando E. Giuliano, Dominic T. Moore, Carolyn I. Sartor, Frances A. Collichio, Lynda Sawyer, Mark L. Graham, Elizabeth Claire Dees, Charles M. Perou and Roderick R. Turner and has published in prestigious journals such as JAMA, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

David W. Ollila

162 papers receiving 7.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

2007 1.6k citations Lisa A. Carey, Elizabeth Claire Dees et al. profile →
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

2017 1.1k citations David W. Ollila et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David W. Ollila United States	44	4.6k	4.3k	2.3k	1.8k	1.7k	173	8.1k
Gerrit‐Jan Liefers Netherlands	52	5.2k 1.1×	2.8k 0.7×	1.4k 0.6×	1.8k 1.0×	1.3k 0.8×	243	9.0k
Isabelle Bedrosian United States	54	4.0k 0.9×	5.8k 1.4×	3.5k 1.5×	2.7k 1.5×	1.3k 0.8×	238	9.3k
Michael S. Sabel United States	51	3.8k 0.8×	2.7k 0.6×	1.4k 0.6×	1.5k 0.8×	3.0k 1.7×	174	8.8k
Tari A. King United States	48	3.9k 0.8×	5.6k 1.3×	3.0k 1.3×	2.1k 1.2×	1.7k 1.0×	288	9.4k
Bernard Asselain France	59	5.2k 1.1×	4.4k 1.0×	2.6k 1.2×	1.8k 1.0×	2.0k 1.2×	323	11.0k
Bernd Gerber Germany	38	3.9k 0.8×	4.4k 1.0×	1.8k 0.8×	1.4k 0.8×	975 0.6×	140	7.3k
Harry D. Bear United States	43	6.6k 1.4×	6.4k 1.5×	3.5k 1.5×	1.8k 1.0×	1.5k 0.8×	173	11.5k
Jens‐Uwe Blohmer Germany	41	6.2k 1.3×	6.3k 1.5×	2.5k 1.1×	1.0k 0.6×	1.1k 0.6×	322	10.0k
Michele A. Gadd United States	44	2.4k 0.5×	3.6k 0.8×	2.4k 1.0×	2.4k 1.4×	703 0.4×	131	6.8k
Gabe S. Sonke Netherlands	42	4.2k 0.9×	2.3k 0.5×	925 0.4×	2.0k 1.1×	1.1k 0.6×	314	8.2k

Countries citing papers authored by David W. Ollila

Since Specialization

Citations

This map shows the geographic impact of David W. Ollila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Ollila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Ollila more than expected).

Fields of papers citing papers by David W. Ollila

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Ollila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Ollila. The network helps show where David W. Ollila may publish in the future.

Co-authorship network of co-authors of David W. Ollila

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Ollila. A scholar is included among the top collaborators of David W. Ollila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Ollila. David W. Ollila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Agala, Chris B., et al.. (2024). Trends in management and related outcomes for occult primary breast cancer. Breast Cancer Research and Treatment. 209(2). 367–374.

Selfridge, Julia M., et al.. (2024). Outcomes and Trends in Axillary Management of Stage cN3b Breast Cancer Patients. Annals of Surgical Oncology. 32(3). 2070–2078.

Lo, Serigne, Gabrielle Williams, Anne Ε. Cust, et al.. (2024). Risk of Death Due to Melanoma and Other Causes in Patients With Thin Cutaneous Melanomas. JAMA Dermatology. 161(2). 167–167. 3 indexed citations

Thai, Christine, Chris B. Agala, Van T. Hoang, et al.. (2024). Nodal Response and Survival After Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer: 20-Year Experience from a Single Institution. Annals of Surgical Oncology. 31(13). 8786–8794. 1 indexed citations

Fleming, Andrew M., Zachary E. Stiles, Paxton V. Dickson, et al.. (2023). Lymph node metastases in young patients with gastrointestinal stromal tumor: A nationwide analysis. Journal of Surgical Oncology. 128(8). 1268–1277.

Gibbs, David C., Nancy E. Thomas, Peter A. Kanetsky, et al.. (2023). Association of functional, inherited vitamin D–binding protein variants with melanoma-specific death. JNCI Cancer Spectrum. 7(5). 1 indexed citations

Roberson, Mya L., Philip M. Spanheimer, Kristalyn K. Gallagher, et al.. (2022). The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment. npj Breast Cancer. 8(1). 27–27. 16 indexed citations

Thornton, Madeline, et al.. (2021). Bridging Endocrine Therapy for HR+/HER2- Resectable Breast Cancer: Is it Safe?. The American Surgeon. 88(3). 471–479. 2 indexed citations

Conway, Kathleen, Yi‐Hsuan Tsai, Sharon N. Edmiston, et al.. (2021). Characterization of the CpG Island Hypermethylated Phenotype Subclass in Primary Melanomas. Journal of Investigative Dermatology. 142(7). 1869–1881.e10. 8 indexed citations

10.

Gaber, Charles, et al.. (2020). Decreased survival and increased recurrence in Merkel cell carcinoma significantly linked with immunosuppression. Journal of Surgical Oncology. 122(4). 653–659. 10 indexed citations

11.

Strassle, Paula D., et al.. (2020). Does acral lentiginous melanoma subtype account for differences in patterns of care in Black patients?. The American Journal of Surgery. 221(4). 706–711. 6 indexed citations

12.

Thomas, Nancy E., Sharon N. Edmiston, Yi‐Hsuan Tsai, et al.. (2018). Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis. American Journal of Dermatopathology. 41(4). 264–272. 26 indexed citations

13.

Golshan, Mehra, Constance Cirrincione, William M. Sikov, et al.. (2016). Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance). Breast Cancer Research and Treatment. 160(2). 297–304. 60 indexed citations

14.

Carey, Lisa A., Donald A. Berry, Constance Cirrincione, et al.. (2015). Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib. Journal of Clinical Oncology. 34(6). 542–549. 263 indexed citations

15.

Thomas, Nancy E., Sharon N. Edmiston, Xin Zhou, et al.. (2014). DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features. Pigment Cell & Melanoma Research. 27(6). 1097–1105. 19 indexed citations

16.

Kimple, Randall J., Janet K. Horton, Chad Livasy, et al.. (2012). Phase I Study and Biomarker Analysis of Lapatinib and Concurrent Radiation for Locally Advanced Breast Cancer. The Oncologist. 17(12). 1496–1503. 12 indexed citations

17.

Horton, Janet K., Jan Halle, Madlyn Ferraro, et al.. (2009). Radiosensitization of Chemotherapy-Refractory, Locally Advanced or Locally Recurrent Breast Cancer With Trastuzumab: A Phase II Trial. International Journal of Radiation Oncology*Biology*Physics. 76(4). 998–1004. 49 indexed citations

18.

Ollila, David W., Heather B. Neuman, Carolyn I. Sartor, Lisa A. Carey, & Nancy Klauber‐DeMore. (2005). Lymphatic mapping and sentinel lymphadenectomy prior to neoadjuvant chemotherapy in patients with large breast cancers. The American Journal of Surgery. 190(3). 371–375. 31 indexed citations

19.

Ollila, David W. & Donald L. Morton. (1999). Tumor doubling time and survival. Journal of Surgical Oncology. 71(4). 249–249. 3 indexed citations

20.

Ollila, David W.. (1998). Therapeutic Effect of Sentinel Lymphadenectomy in T1 Breast Cancer. Archives of Surgery. 133(6). 647–647. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact